Clinical Trial Update: A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating NXT007 versus Factor VIII prophylaxis in Hemophilia A is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• NXT007

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hemophilia A | Phase 3 | Status: RECRUITING